Oncology PCR Markers Market: By PCR Markers Type (Taqman Probe, SYBR Green, RAPD, ISSR, EST-SSR, Microsatellite, CAPS), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Renal Cancer, Others), By End-User (Hospitals, Cancer Care Centers, Diagnostic Labs, Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Oncology PCR Markers Market size was valued at USD 13,683.2 million in 2023 and is expected to grow at an 8.1% CAGR from 2024 to 2030. Oncology PCR markers play a crucial role in this by detecting minute quantities of RNA molecules indicative of cancerous cells. Tumor-specific biomarkers, such as oncogenes, tumor suppressor genes, and fusion genes, serve as targets for RT-PCR analysis. A molecular oncology PCR marker is used to identify the size of the detected PCR product from a suspected oncology sample. The growth of the oncology PCR market can be largely attributed to the factors, such as the rising prevalence of cancer, worldwide, technological advancements in diagnostic testing, and increasing demand for point-of-care testing. The rising prevalence of cancer cases across the world is contributing to the increasing demand for diagnosis, which is boosting the oncology PCR markers market. Moreover, behavioral and dietary changes such as low physical activity, high tobacco and alcohol uptake, low intake of healthy food, and obesity account for the increase in cancer cases globally.

According to the World Health Organization (WHO), cancer accounted for approximately 10 million deaths in 2020. Additionally, due to the increasing technological advancements in diagnostic testing, there is a growing usage of molecular diagnostic tests like PCR for oncology. Several advancements are being made in cancer genome sequencing, computational analysis, tumor models, and innovative cancer research methods. For instance, Roche Molecular Systems, Inc. developed the Cobas EGFR Mutation Test for non-small cell lung cancer patients and received approval from the USFDA in 2020 and is a real-time PCR test to detect 42 mutations of the epidermal growth factor receptor (EGFR) gene. Moreover, molecular tests using PCR are being used more frequently due to improvements in diagnostic testing technologies. The expansion in the field of molecular biotechnology, rising demand for synthetic biology, and increasing investment in R&D by key players are the main factors fueling the rapid growth of the oncology PCR markets market.

However, the high cost of oncology PCR markers tests, lack of skilled workforce, and stringent regulatory framework are some of the factors impeding the market growth. The use of oncology PCR markers tools for oncology is predicted to rise due to increased patient and healthcare professional awareness of the importance of early cancer detection and distinction. Moreover, the PCR technology holds the potential for the highest revenue share. This can be attributed to its growing utilization in research labs and the increased need for enhanced diagnostics.

Oncology PCR Markers Market Key Developments:
  • In April 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1Mutation Detection Kit for Breast cancer.

Oncology PCR Markers Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Oncology PCR Markers Market Dynamics

The rising prevalence of cancer cases across the world is contributing to the increasing demand for diagnosis, which is boosting the oncology PCR markers market. Moreover, behavioral and dietary changes such as low physical activity, high tobacco and alcohol uptake, low intake of healthy food, and obesity account for the increase in cancer cases globally. The improvement in healthcare infrastructure, technological advancements, and increase in healthcare expenditure by the government as well as key market players has contributed to the growth and increasing demand for the oncology PCR markers market. However, the high cost of oncology PCR markers tests, lack of skilled workforce, and stringent regulatory framework are some of the factors impeding the market growth. Despite of this, the use of oncology PCR markers is predicted to rise due to increased patient and healthcare professional awareness of the importance of early cancer detection and distinction.

Oncology PCR Markers Market Segmentation

By PCR Marker Type
  • Taqman probe
  • SYBR Green
  • RAPD
  • ISSR
  • EST-SSR
  • Microsatellite
  • CAPS
By Cancer Type
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Renal Cancer
  • Others
By End User
  • Hospitals
  • Cancer Care Centers
  • Diagnostic Labs
  • Others

Frequently Asked Questions

Oncology PCR Markers Market was valued at USD 13,683.2 million in 2023 and is expected to grow at an 8.1% CAGR from 2024 to 2030.

F. Hoffmann-La Roche Ltd., Abbott, Thermo Fisher Scientific Ltd., Bio-Rad Laboratories, Inc., and CENTOGENE N.V. are some of the major players operating in the oncology PCR markers market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period.

North America accounts for the largest market share and is expected to be the primary market driver in the oncology PCR markers market.

The high cost of oncology PCR markers tests, lack of skilled workforce, and stringent regulatory framework are expected to limit the growth of the oncology PCR markers market

Key Features of the Reports

  • The oncology PCR markers market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
1.Executive Summary
2.Global Oncology PCR Markers Market Introduction 
2.1.Global Oncology PCR Markers Market  - Taxonomy
2.2.Global Oncology PCR Markers Market  - Definitions
2.2.1.PCR Marker Type
2.2.2.Cancer Type
2.2.3.End-user
2.2.4.Region
3.Global Oncology PCR Markers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Oncology PCR Markers Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Oncology PCR Markers Market  By PCR Marker Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Taqman probe
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. SYBR Green
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. RAPD
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. ISSR
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. EST-SSR
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Microsatellite
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. CAPS
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6.Global Oncology PCR Markers Market  By Cancer Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Lung Cancer
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Breast Cancer
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Colorectal Cancer
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Pancreatic Cancer
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Renal Cancer
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Others
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7.Global Oncology PCR Markers Market  By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cancer Care Centers
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Diagnostic Labs
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Oncology PCR Markers Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Oncology PCR Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. PCR Marker Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Taqman probe
9.1.2.SYBR Green
9.1.3.RAPD
9.1.4.ISSR
9.1.5.EST-SSR
9.1.6.Microsatellite
9.1.7.CAPS
9.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Lung Cancer
9.2.2.Breast Cancer
9.2.3.Colorectal Cancer
9.2.4.Pancreatic Cancer
9.2.5.Renal Cancer
9.2.6.Others
9.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Cancer Care Centers
9.3.3.Diagnostic Labs
9.3.4.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Oncology PCR Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. PCR Marker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Taqman probe
10.1.2.SYBR Green
10.1.3.RAPD
10.1.4.ISSR
10.1.5.EST-SSR
10.1.6.Microsatellite
10.1.7.CAPS
10.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Lung Cancer
10.2.2.Breast Cancer
10.2.3.Colorectal Cancer
10.2.4.Pancreatic Cancer
10.2.5.Renal Cancer
10.2.6.Others
10.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Cancer Care Centers
10.3.3.Diagnostic Labs
10.3.4.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Oncology PCR Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. PCR Marker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Taqman probe
11.1.2.SYBR Green
11.1.3.RAPD
11.1.4.ISSR
11.1.5.EST-SSR
11.1.6.Microsatellite
11.1.7.CAPS
11.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Lung Cancer
11.2.2.Breast Cancer
11.2.3.Colorectal Cancer
11.2.4.Pancreatic Cancer
11.2.5.Renal Cancer
11.2.6.Others
11.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Cancer Care Centers
11.3.3.Diagnostic Labs
11.3.4.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Oncology PCR Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. PCR Marker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Taqman probe
12.1.2.SYBR Green
12.1.3.RAPD
12.1.4.ISSR
12.1.5.EST-SSR
12.1.6.Microsatellite
12.1.7.CAPS
12.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Lung Cancer
12.2.2.Breast Cancer
12.2.3.Colorectal Cancer
12.2.4.Pancreatic Cancer
12.2.5.Renal Cancer
12.2.6.Others
12.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Cancer Care Centers
12.3.3.Diagnostic Labs
12.3.4.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Oncology PCR Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. PCR Marker Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Taqman probe
13.1.2.SYBR Green
13.1.3.RAPD
13.1.4.ISSR
13.1.5.EST-SSR
13.1.6.Microsatellite
13.1.7.CAPS
13.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Lung Cancer
13.2.2.Breast Cancer
13.2.3.Colorectal Cancer
13.2.4.Pancreatic Cancer
13.2.5.Renal Cancer
13.2.6.Others
13.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Cancer Care Centers
13.3.3.Diagnostic Labs
13.3.4.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Hoffmann-La Roche Ltd.
14.2.2.Abbott
14.2.3.Thermo Fisher Scientific Ltd.
14.2.4.Bio-Rad Laboratories, Inc.
14.2.5.CENTOGENE N.V.
14.2.6.R&D System
14.2.7.Myriad RBM
14.2.8.PhenoPath
14.2.9.Quest Diagnostics
14.2.10.Personal Genome Diagnostics
15. Research Methodology 
16. Appendix and Abbreviations 
  • Hoffmann-La Roche Ltd.
  • Abbott
  • Thermo Fisher Scientific Ltd.
  • Bio-Rad Laboratories, Inc.
  • CENTOGENE N.V.
  • R&D System
  • Myriad RBM
  • PhenoPath
  • Quest Diagnostics
  • Personal Genome Diagnostics

Adjacent Markets